State, regional differences in melanoma rates 2003 vs 2013

December 28, 2016

A new research letter published online by JAMA Dermatology compares melanoma death and incidence by states and in four geographic regions.

Melanoma death and incidence rates vary among states, partly because of demographic differences.

Robert P. Dellavalle, M.D., Ph.D., M.S.P.H., of the Denver Veterans Affairs Medical Center and the University of Colorado School of Medicine, Aurora, and coauthors used a publicly available database to analyze melanoma death and incidence rates by state and geographic region. Researchers report: * 11 of the 49 states with reported melanoma incidence rates saw a decrease and 38 states had an increase.

"Promoting greater awareness of skin cancer through public health programs has been associated with increased documentation and incidence rates. Lower death rates may further indicate that better treatment may be prolonging the life of patients with melanoma. Further research into the prevalence of melanoma in these four geographic regions is needed," the article concludes.

(JAMA Dermatology. Published online December 28, 2016. doi:10.1001/jamadermatol.2016.4625; available pre-embargo at the For The Media website.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Also available in JAMA Dermatology: The research letter, "Indoor Tanning and Skin Cancer Risk Among Diverse U.S. Youth: Results From a National Sample," by Aaron J. Blashill, Ph.D., of San Diego State University, also is available on the For The Media website.

To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2016.4625

The JAMA Network Journals

Related Melanoma Articles from Brightsurf:

Boosting treatments for metastatic melanoma
University of Cincinnati clinician-scientist Soma Sengupta, MD, PhD, says that new findings from her and Daniel Pomeranz Krummel's, PhD, team might have identified a treatment-boosting drug to enhance effectiveness of therapies for metastatic cancer and make them less toxic, giving patients a fighting chance at survival and improved quality of life.

A promising new tool in the fight against melanoma
An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.

New targets for melanoma treatment
A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute (ONJCRI) has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.

Innovative smartphone-camera adaptation images melanoma and non-melanoma
An article published in the Journal of Biomedical Optics (JBO), ''Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring,'' shows that standard smartphone technology can be adapted to image skin lesions, providing a low-cost, accessible medical diagnostic tool for skin cancer.

Antihistamines may help patients with malignant melanoma
Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma?

Blood test for deadly eye melanoma
A simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye.

Analysis of melanoma in US by age groups
This study used registry data to determine annual rates of melanoma in pediatric, adolescent, young adult and adult age groups, and the findings suggest an apparent decrease among adolescent and young adults between 2006 and 2015 but increases in older adults.

Vitamin D dials down the aggression in melanoma cells
Vitamin D influences the behaviour of melanoma cells in the lab by making them less aggressive, Cancer Research UK scientists have found.

B cells linked to immunotherapy for melanoma
Immunotherapy uses our body's own immune system to fight cancer.

Five things to know about melanoma
'Five things to know about ... melanoma' in CMAJ (Canadian Medical Association Journal) provides a brief overview of this malignant skin cancer for physicians and patients.

Read More: Melanoma News and Melanoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.